C3F8
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for C3F8, covering 2016-07-26 to 2020-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD [Phase 2, Phase 3]